Myths and Shibboleths in Nephrology
Latest Publications

TOTAL DOCUMENTS

27

(FIVE YEARS 0)

H-INDEX

0

(FIVE YEARS 0)

Published By Springer Netherlands

9781402006166, 9789401004077

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Myth: Urinary tract infection is more prevalent in diabetes

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_7 ◽

2002 ◽

pp. 19-20

Author(s):

Iram Anees

Keyword(s):

Urinary Tract Infection ◽

Urinary Tract ◽

Tract Infection

Download Full-text

Myth: Mortality in chronic hemodialysis is greater in the U.S. than in Europe and Japan

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_18 ◽

2002 ◽

pp. 48-50

Author(s):

Sidhartha Pani

Keyword(s):

Chronic Hemodialysis ◽

The U.S

Download Full-text

Myth: Surgical intervention and prompt nephrectomy are preferred in emphysematous pyelonephritis

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_17 ◽

2002 ◽

pp. 45-47

Author(s):

Iram Anees

Keyword(s):

Surgical Intervention ◽

Emphysematous Pyelonephritis

Download Full-text

Myth: Peritoneal dialysis is equivalent to hemodialysis

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_11 ◽

2002 ◽

pp. 28-31

Author(s):

Jasmohan S. Bajaj

Keyword(s):

Peritoneal Dialysis

Download Full-text

Myth: Type 1 diabetes is more likely than type 2 diabetes to lead to nephropathy and ESRD

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_8 ◽

2002 ◽

pp. 21-23

Author(s):

Moyna Kapoor

Keyword(s):

Type 2 Diabetes ◽

Type 1 Diabetes

Download Full-text

Myth: Angiotensin converting enzyme inhibitors (ACEi) are superior to other antihypertensive drugs because of their renoprotective properties

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_4 ◽

2002 ◽

pp. 8-12

Author(s):

Moro O. Salifu

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Antihypertensive Drugs ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors

Download Full-text

Myth: Patients with severe cerebrovascular accidents (CVA) require long-term bladder catheters

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_24 ◽

2002 ◽

pp. 62-64

Author(s):

Mary C. Mallappallil

Keyword(s):

Cerebrovascular Accidents

Download Full-text

Myth: Fish oil is effective therapy for IgA nephropathy

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_22 ◽

2002 ◽

pp. 57-58

Author(s):

Daniel J. Wolde

Keyword(s):

Fish Oil ◽

Iga Nephropathy ◽

Effective Therapy

Download Full-text

Myth: Administration of active vitamin D metabolites is beneficial in patients with advanced chronic renal failure (pre end-stage renal disease)

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_16 ◽

2002 ◽

pp. 43-44

Author(s):

Hanna von Hardenberg

Keyword(s):

Vitamin D ◽

Renal Failure ◽

Chronic Renal Failure ◽

Renal Disease ◽

End Stage Renal Disease ◽

Vitamin D Metabolites ◽

Active Vitamin ◽

Active Vitamin D ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Myth: Living related pancreas after kidney transplantation is preferable to cadaveric simultaneous pancreas-kidney transplantation

Myths and Shibboleths in Nephrology ◽

10.1007/978-94-010-0407-7_15 ◽

2002 ◽

pp. 40-42

Author(s):

Brian Whang

Keyword(s):

Kidney Transplantation ◽

Pancreas Kidney Transplantation ◽

Simultaneous Pancreas Kidney ◽

Living Related ◽

Simultaneous Pancreas Kidney Transplantation

Download Full-text